Company

miRecule

Rocket Ship Rating

Rocket Ship Rating: 79 out of 100

Realizing the potential of tissue-targeted RNA therapies

Also known as miRecule, Inc.

Biotech & therapeutics

Status: Operatingas of 2026-09-17
Business model: B2B
Headquarters: Gaithersburg, MD, United States
Legal name: miRecule, Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

is a biotechnology company developing RNA therapies for cancer and muscular dystrophy.

Funding snapshot

Total raised: $2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $1.5M2019-10-17

Funding rounds

Round, 2019: $1.5M2019-10-17, SEC form D sold, 3 investors
Round, 2019: $500K2019-10-11, SEC form D sold, 9 investors

Products

Other: DREAmiR™